YILI CHUANNING BIOTECHNOLOGY CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.3 CNY | +0.45% |
|
-4.73% | +58.33% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Yili Chuanning Biotechnology Co Ltd is a China-based company mainly engaged in the research, development and industrialization of biological fermentation technology. The Company's products mainly include erythromycin thiocyanate, cephalosporin intermediates, penicillin intermediates, crude ursodeoxycholic acid, coenzyme Q10 mycelium and others. The Company's products are mainly exported to countries such as India.
Sector
Pharmaceuticals
Calendar
2024-08-19
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
13.3
CNY
Average target price
10.6
CNY
Spread / Average Target
-20.30%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +58.33% | 4.09B | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| +9.78% | 210B | |
| -5.52% | 206B | |
| +6.17% | 164B |
- Stock Market
- Equities
- 301301 Stock
- News Yili Chuanning Biotechnology Co.,Ltd.
- Yili Chuanning Biotechnology Signs Cooperation Deal With Jinhui Technology
